FLUAD
INFLUENZA A VIRUS A/Missouri/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
Listed by Seqirus, Inc.
- Strength
- 15 ug/.5mL, 15 ug/.5mL, 15 ug/.5mL
- Form
- Injection, Suspension
- Route
- Intramuscular
What it contains
- Influenza A Virus A/missouri/11/2025 Ivr-279 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL
- Influenza A Virus A/michigan/105/2025 Ivr-285 (h3n2) Antigen (formaldehyde Inactivated) 15 ug/.5mL
- Influenza B Virus B/tokyo/eis13-175/2025 Antigen (formaldehyde Inactivated) 15 ug/.5mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Injection, Suspension |
|---|---|
| Route | Intramuscular |
| Approval route | BLA — biologic licence |
| NDC code | 70461-026 |
| FDA application | BLA125510 |
| Package sizes listed | 1 |
| Marketed since | July 2026 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.